Welcome to our dedicated page for Health In Tech SEC filings (Ticker: HIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Health In Tech, Inc. filings document material-event disclosures for a Nevada operating company with Class A common stock listed on the Nasdaq Capital Market under HIT. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD materials, investor presentations and conference-call transcripts.
The filing record also addresses capital-structure matters, including a private investment in public equity financing, and governance disclosures involving executive officer departures, compensatory arrangements and related consulting agreements. The company identifies as an emerging growth company in its Exchange Act reports.
Health In Tech, Inc. Chief Executive Officer and major shareholder Tim Donald Johnson reported a tax-related share disposition. He surrendered 46,768 shares of Class A Common Stock to the company at $1.05 per share to cover tax withholding tied to vesting restricted stock, rather than selling shares on the open market.
After this transaction, he directly holds 23,427,909 Class A shares, consisting of 984,353 restricted and 22,443,556 unrestricted shares. The footnotes also state that this figure excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase Class A shares.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin reported a disposition of 28,451 shares of Class A Common Stock on June 15, 2026. These shares were surrendered to the company to satisfy tax withholding obligations tied to the vesting of restricted stock, not sold in the open market.
After this tax-withholding disposition, LinLin directly holds 9,055,300 Class A shares, consisting of 1,030,065 restricted shares and 8,025,235 unrestricted shares. The footnotes also state that this figure excludes 2,700,000 shares of Class B Common Stock and 711,510 stock options.
Health In Tech, Inc. filed a shelf registration on Form S-3 to register up to $300,000,000 of securities to be offered from time to time after this Registration Statement becomes effective. The shelf covers Common Stock, Preferred Stock, Warrants, Debt Securities, Subscription Rights and Units.
The prospectus states proceeds will be used for general corporate purposes, including working capital, capital expenditures, research and development and acquisitions. As of June 10, 2026, the company reports 53,842,109 shares of Class A Common Stock and 11,700,000 shares of Class B Common Stock issued and outstanding; 1,900,825 options are outstanding.
Lockett Jonathan Del reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. Chief Strategy Officer Jonathan Del Lockett received a grant of 50,000 restricted shares of Class A Common Stock under the Health In Tech Equity Incentive Plan. These shares are subject to performance-based milestones and will be forfeited if those milestones are not achieved.
If the first milestone is met by on or before July 1, 2026, 20,000 shares will vest in equal monthly installments over 12 months. If a second milestone is met by on or before August 15, 2026, the remaining 30,000 shares will vest in equal monthly installments over 12 months. Following this award, he directly holds 143,539 shares, consisting of 78,985 unrestricted and 64,554 restricted shares, and also holds options to purchase 165,085 additional shares.
Health In Tech, Inc. is registering up to 5,600,000 shares of Class A Common Stock for resale by the selling stockholders.
This prospectus forms part of a shelf registration that permits the named selling stockholders to resell their Class A Common Stock from time to time; the company will not receive any proceeds from those resales. The Registration Rights Agreement arose from a PIPE Offering that closed on March 27, 2026.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin reported a tax-related share disposition. On May 14, 2026, she surrendered 23,324 shares of Class A Common Stock at $1.23 per share to the company to satisfy tax withholding obligations tied to vesting restricted stock.
After this transaction, she directly holds 9,083,751 Class A shares, including 1,060,738 restricted and 8,023,013 unrestricted shares. The filing notes this does not include 2,700,000 Class B shares or 711,510 stock options.
Health In Tech, Inc. Chief Executive Officer and 10% owner Tim Donald Johnson reported a tax-related share disposition. He surrendered 39,924 shares of Class A Common Stock at $1.23 per share to the company to satisfy tax withholding obligations tied to vesting restricted stock awards.
After this transaction, he directly holds 23,474,677 Class A shares, consisting of 1,037,478 restricted and 22,437,199 unrestricted Class A shares. This was a tax-withholding disposition rather than an open-market sale.
Health In Tech, Inc. Chief Growth Officer Hasan Zain Syed reported a compensation-related share disposition tied to tax withholding. On restricted stock vesting, he surrendered 4,205 shares of Class A Common Stock at $1.23 per share to cover tax obligations rather than selling them in the market.
After this transaction, Syed directly holds 212,347 Class A shares, including 205,680 restricted shares and 6,667 unrestricted shares. This filing reflects routine tax withholding associated with previously reported restricted stock awards.
Health In Tech, Inc. reports Q1 2026 results with total revenue of $8,771,646 and a net loss of $1,588,281, compared with net income in the prior-year quarter. Revenue grew mainly from fees, while underwriting modeling revenue declined.
Cost of revenues and operating expenses rose sharply, driven by higher sales and marketing, research and development, and amortization of capitalized software, compressing gross profit to $4,509,399. The company strengthened liquidity through a March 2026 PIPE, issuing 5,600,000 Class A shares at $1.25 per share for net proceeds of $6,381,000, lifting cash and cash equivalents to $10,325,208 at quarter end.